WILMINGTON – The Chemours Company, a global chemistry and advanced materials company, announced Monday afternoon that it will explore the sale of its mining solutions division in order to refocus its business and boost share ...
WILMINGTON – A month after spinning off its nutrition and bioscience division in a billion-dollar deal, DuPont is back on the hunt, acquiring a Chinese performance materials company for $2.3 billion. On Monday morning, DuPont ...
WILMINGTON – As the world begins working toward reducing greenhouse gases that are leading to climate change, industries are going to face a number of challenges to eliminate the harmful pollution from their operations. Carbon ...
WILMINGTON – With Congressional Democrats reportedly preparing to overturn a more than decade-long ban on federal earmarks, U.S. Sen. Chris Coons (D-Del.) told state biotech leaders that he anticipated lobbying for more investment in Delaware’s ...
WILMINGTON – DuPont closed its long-awaited merger of its Nutrition & Biosciences division with International Flavors & Fragrances Inc. (IFF) on Monday, while also announcing that it has reached a deal to sell its clean ...
BEAR – When the former owner of IMS Chemblend, a specialty chemical blending and packaging company, sought to retire last year, the small firm faced an uncertain future. All of that changed after former customer ...
WILMINGTON – The trio of companies that emerged from the legacy of E. I. du Pont de Nemours and Company – DuPont, Chemours and Corteva – have reached a settlement worth as much as $4 ...
WILMINGTON – A new state advisory group intends to increase Delaware’s spotlight as a science and technology innovation hub, helping the state remain competitive in the region for growing and relocating companies. The Science & ...
From the earliest scientific advancements made at DuPont more than two centuries ago to the brand-new cancer therapies being developed by Incyte, Delaware has a long history of laboratory-based research and development. As the competition ...
WILMINGTON – The COVID-19 pandemic appears to have killed the deal between DuPont and Delle Donne & Associates that would have seen a large portion of the chemical manufacturing giant’s headquarters campus redeveloped. On Friday ...
